Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Cytokine storm in COVID-19: the current evidence and treatment strategies
Y Tang, J Liu, D Zhang, Z Xu, J Ji, C Wen - Frontiers in immunology, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has …
[HTML][HTML] Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis
The coronavirus-disease 2019 (COVID-19) was announced as a global pandemic by the
World Health Organization. Challenges arise concerning how to optimally support the …
World Health Organization. Challenges arise concerning how to optimally support the …
Drug repurposing approach to fight COVID-19
Currently, there are no treatment options available for the deadly contagious disease,
coronavirus disease 2019 (COVID-19). Drug repurposing is a process of identifying new …
coronavirus disease 2019 (COVID-19). Drug repurposing is a process of identifying new …
[HTML][HTML] COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain
M Goicoechea, LAS Cámara, N Macías… - Kidney international, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia emerged in
Wuhan, China in December 2019. Unfortunately, there is a lack of evidence about the …
Wuhan, China in December 2019. Unfortunately, there is a lack of evidence about the …
Presentation and outcomes of patients with ESKD and COVID-19
AM Valeri, SY Robbins-Juarez… - Journal of the …, 2020 - journals.lww.com
Background The relative immunosuppression and high prevalence of comorbidities in
patients with ESKD on dialysis raise concerns that they may have an elevated risk of severe …
patients with ESKD on dialysis raise concerns that they may have an elevated risk of severe …
Tocilizumab for the treatment of severe coronavirus disease 2019
Abstract Tocilizumab, an interleukin‐6 inhibitor, may ameliorate the inflammatory
manifestations associated with severe coronavirus disease 2019 (COVID‐19) and thus …
manifestations associated with severe coronavirus disease 2019 (COVID‐19) and thus …
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
A subset of patients with severe COVID-19 develop profound inflammation and multi-organ
dysfunction consistent with a “Cytokine Storm Syndrome”(CSS). In this review we compare …
dysfunction consistent with a “Cytokine Storm Syndrome”(CSS). In this review we compare …
Supportive treatment with tocilizumab for COVID-19: a systematic review
SK Alzghari, VS Acuña - Journal of Clinical Virology, 2020 - Elsevier
2. Methods A systematic review was performed according to the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was …
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature search was …
COVID-19 and gastrointestinal disease: implications for the gastroenterologist
Background: COVID-19 was initially considered a respiratory disease but the SARS-CoV-2
virus can lead to serious systemic consequences affecting major organs including the …
virus can lead to serious systemic consequences affecting major organs including the …
[HTML][HTML] COVID-19 and the kidney: from epidemiology to clinical practice
I Gagliardi, G Patella, A Michael, R Serra… - Journal of clinical …, 2020 - mdpi.com
The new respiratory infectious disease coronavirus disease 2019 (COVID-19) that
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …